Ra-224-Radium Chloride (224-SpondylAT®)

224Ra-Radium Chloride was used for a long time between the [...]

I-131-Tositumomab (Bexxar®)

131I-Tositumomab is a radiolabeled anti-CD20 antibody launched in 2003 under [...]

Y-90-OPS201 (SOMTher®)

90Y-OPS201 (90Y-DOTA-JR11, 90Y-SOMTher®) is a proprietary drug that specifically binds [...]

Y-90-DOTATOC (Edotreotide)

90Y-Edotreotide (90Y-DOTATOC, 90Y-Onalta®) is a drug which is actually developed [...]

Y-90-DOTALAN (Lanreotide)

90Y-DOTALAN (90Y-Lanreotide, 90Y-Somatulin) is a generic drug that specifically binds [...]

Th-227-Epratuzumab (Th-227-BAY1862864)

227Th-Epratuzumab (227Th-BAY1862864 is a CD-22 thorium conjugate targeting relapsed or [...]

Ac-225-PSMA-617

225Ac-PSMA-617 is the next generation of prostate cancer treatment following [...]

Ac-225-Lintuzumab (Ac-225 Actimab-A™)

225Ac-Lintuzumab (225Ac-Actimab-A™, 225Ac-DOTA-huM195, 225Ac-DOTA-Lintuzumab) is the new name of the [...]

Go to Top